Editorial: Pharmacokinetic-pharmacodynamic model of drugs and their pharmacokinetic differences between normal and disease states

被引：0
|
作者：
Gong, Zipeng [1 ,2 ,3 ]
Chen, Ruixing [1 ]
Ye, Ling [4 ]
Ma, Guo [5 ]
Xian, Yanfang [6 ]
Kulkarni, Kaustubh [7 ]
机构：
[1] Guizhou Med Univ, Sch Pharm, State Key Lab Funct & Applicat Med Plants, Guizhou Prov Key Lab Pharmaceut, Guiyang, Peoples R China
[2] Zunyi Med Univ, Key Lab Basic Pharmacol, Minist Educ, Zunyi, Peoples R China
[3] Guizhou Med Univ, Guizhou Prov Engn Res Ctr Dev & Applicat Ethn Med, Guiyang, Peoples R China
[4] Southern Med Univ, Sch Pharmaceut Sci, NMPA Key Lab Res & Evaluat Drug Metab, Guangdong Prov Key Lab New Drug Screening, Guangzhou 510515, Peoples R China
[5] Fudan Univ, Sch Pharm, Shanghai, Peoples R China
[6] Chinese Univ Hong Kong, Fac Med, Sch Chinese Med, Shatin, Hong Kong, Peoples R China
[7] Boundless Bio Inc, San Diego, CA USA
来源：
FRONTIERS IN PHARMACOLOGY | 2024年 / 15卷
基金：
中国国家自然科学基金;
关键词：
normal status; disease states; metabolizing enzymes; transporters; pharmacokinetic-pharmacodynamic link model;
D O I：
10.3389/fphar.2024.1451176
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Atazanavir-bilirubin interaction: a pharmacokinetic-pharmacodynamic model
    Lozano, Roberto
    Domeque, Nieves
    Apesteguia, Alberto-Fermin
    CLINICAL PHARMACOLOGY-ADVANCES AND APPLICATIONS, 2013, 5 : 153 - 159
  • [42] Exploring Differences in Pharmacometrics of Rabeprazole between Genders via Population Pharmacokinetic-Pharmacodynamic Modeling
    Jeong, Seung-Hyun
    Jang, Ji-Hun
    Lee, Yong-Bok
    BIOMEDICINES, 2023, 11 (11)
  • [43] CONCEPTS AND USEFULNESS OF PHARMACOKINETIC-PHARMACODYNAMIC MODELING
    HOLFORD, NHG
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 1990, 4 : S93 - S101
  • [44] APPLICATION OF PHARMACOKINETIC-PHARMACODYNAMIC MODELING TO ANALGESIA
    INTURRISI, CE
    COLBURN, WA
    ADVANCES IN PAIN RESEARCH AND THERAPY, 1986, 8 : 441 - 452
  • [45] PHARMACOKINETIC-PHARMACODYNAMIC RELATIONSHIPS OF MORPHINE IN NEONATES
    CHAY, PCW
    DUFFY, BJ
    WALKER, JS
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1992, 51 (03) : 334 - 342
  • [46] Pharmacokinetic-pharmacodynamic modelling of danofloxacin in turkeys
    Haritova, A. M.
    Rusenova, N. V.
    Parvanov, P. R.
    Lashev, L. D.
    Fink-Gremmels, J.
    VETERINARY RESEARCH COMMUNICATIONS, 2006, 30 (07) : 775 - 789
  • [47] Gliclazide:: Pharmacokinetic-pharmacodynamic relationships in rats
    Stetinova, V.
    Kvetina, J.
    Pastera, J.
    Polaskova, A.
    Prazakova, M.
    BIOPHARMACEUTICS & DRUG DISPOSITION, 2007, 28 (05) : 241 - 248
  • [48] Pharmacokinetic-pharmacodynamic modelling: History and perspectives
    Csajka, Chantal
    Verotta, Davide
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2006, 33 (03) : 227 - 279
  • [49] PHARMACOKINETIC-PHARMACODYNAMIC AND METABOLITE MODELING WITH TOPFIT
    TANSWELL, P
    HEINZEL, G
    WEISENBERGER, H
    ROTH, W
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 1995, 33 (10) : 550 - 554
  • [50] Development of translational pharmacokinetic-pharmacodynamic models
    Mager, D. E.
    Jusko, W. J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 83 (06) : 909 - 912
12345